Document is current
Any future updates will be listed below
-
Authors
El Bounkari, Omar https://orcid.org/0000-0002-3051-2096
Zan, Chunfang
Yang, Bishan
Ebert, Simon https://orcid.org/0009-0004-5776-2089
Wagner, Jonas
Bugar, Elina
Kramer, Naomi
Bourilhon, Priscila
Kontos, Christos
Zarwel, Marlies
Sinitski, Dzmitry
Milic, Jelena
Jansen, Yvonne
Kempf, Wolfgang E.
Sachs, Nadja https://orcid.org/0000-0001-8031-017X
Maegdefessel, Lars https://orcid.org/0000-0001-5228-2634
Ji, Hao
Gokce, Ozgun
Riols, Fabien
Haid, Mark https://orcid.org/0000-0001-6118-1333
Gerra, Simona
Hoffmann, Adrian https://orcid.org/0009-0000-0661-2321
Brandhofer, Markus https://orcid.org/0000-0002-1629-8353
Avdic, Maida
Bucala, Richard
Megens, Remco T. A. https://orcid.org/0000-0001-9871-6696
Willemsen, Nienke
Messerer, Denise
Schulz, Christian https://orcid.org/0000-0002-8149-0747
Bartelt, Alexander https://orcid.org/0000-0001-7840-3991
Harm, Tobias
Rath, Dominik
Döring, Yvonne https://orcid.org/0000-0001-9307-3396
Gawaz, Meinrad https://orcid.org/0000-0003-1124-9592
Weber, Christian
Kapurniotu, Aphrodite
Bernhagen, Jürgen https://orcid.org/0000-0003-2996-2652
- License Information
-
More Information
Article History
Received: 24 January 2024
Accepted: 25 February 2025
First Online: 7 March 2025
Competing interests
: J.B., R.B., and C.W. are co-inventors of patents covering anti-MIF strategies for inflammatory and cardiovascular diseases. C.Ko., A.K., O.E., and J.B. are co-inventors of a patent application covering MIF-binding CXCR4 ectodomain mimics for inflammatory and cardiovascular diseases. The remaining authors declare no competing interests.
